NSCLC STAGE II

Clinical trials for NSCLC STAGE II explained in plain language.

Never miss a new study

Get alerted when new NSCLC STAGE II trials appear

Sign up with your email to follow new studies for NSCLC STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

New hope for lung cancer patients who Can't tolerate chemo

Disease control Ongoing

This study is testing whether combining a drug called durvalumab (an immunotherapy) with radiation therapy can help control locally advanced non-small cell lung cancer. It is for patients who are not eligible for the standard treatment of chemotherapy followed by radiation, often…

Matched conditions: NSCLC STAGE II

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

NSCLC STAGE II

Get alerted when new NSCLC STAGE II trials appear

New hope for lung cancer patients who Can't tolerate chemo